Patents Assigned to Greiner Bio-One North America, Inc.
  • Magnetic stem cell therapy for lesions
    Patent number: 11033623
    Abstract: Magnetic cells plus a magnet are used to treat ED and other bodily lesions, whereby the magnetic cells are held in at or near the location of the lesion with a magnetic field for a period of time until efficacy is established. The cells can be any cell type, including stem cells, autologous cells, recombinant cells, combinations thereof and the like.
    Type: Grant
    Filed: June 7, 2018
    Date of Patent: June 15, 2021
    Assignee: GREINER BIO-ONE NORTH AMERICA, INC.
    Inventors: Glauco Souza, Hubert Tseng
  • Hardware for magnetic 3D culture
    Patent number: 10407660
    Abstract: Devices for magnetic 3d culture are described including magnetic lids/bases for single Petri plates, adjustable height cap for same, as well similar devices for multi-magnet culture plates. A pen-like device for sterilely lifting and moving cells is also described, and this magnetic pipettor can also exist in multi-well magnetic pipettor formats.
    Type: Grant
    Filed: February 7, 2013
    Date of Patent: September 10, 2019
    Assignee: Greiner Bio-One North America, Inc.
    Inventor: Glauco Souza
  • 3D cell viability assay
    Patent number: 10288603
    Abstract: Cells are grown in 3D culture and topological features obtained by photomicrography are correlated to cell viability and cell cell interactions.
    Type: Grant
    Filed: January 13, 2012
    Date of Patent: May 14, 2019
    Assignee: Greiner Bio-One North America, Inc.
    Inventor: Glauco R. Souza
  • Magnetic extracellular matrix
    Patent number: 10265396
    Abstract: Methods of making and using a magnetic ECM are disclosed. The ECM comprises positively and negatively charged nanoparticles, wherein one of said nanoparticles contains a magnetically responsive element. When the magnetic ECM is seeded with cells, the cells will be magnetized and can be levitated for 3-D cell culture.
    Type: Grant
    Filed: September 18, 2017
    Date of Patent: April 23, 2019
    Assignee: Greiner Bio-One North America, Inc.
    Inventor: Glauco R. Souza